|
|
||||||||
Mayo Clinic and Mayo Foundation, Rochester, Minnesota
Correspondence: For reprints contact: R. A. Rizza, Mayo Clinic, 200 First St., S.W., Rochester, MN 55901.
ABSTRACT
[131I] 19-iodocholesterol (I-131 C) correctly located adrenocortical adenomas in four patients who had no clinical or biochemical evidence of excessive steroid production. Three of the four "nonfunctioning" adenomas showed significant quantities of lipid histologically. To clarify the discordance between uptake and adrenal-steroid excretion, the subcellular location of 1-131 C was studied. Normal rats and rats treated with ACTH or aminoglutethimide (AG) were injected intravenously with I-131 C or [3H] cholesterol (H-3 C) and killed after three days. The homogenized adrenals were subjected to subcellular fractionation.
Treatment with AG increased both the amount and the percentage of both I-131 C and H-3 C contained in the lipid fraction. ACTH treatment decreased H-3 C content but did not change I-131 C content in the lipid layer, suggesting an impairment of I-131 C mobilization from lipid droplets. The data demonstrate that excess steroid production is not necessary for I-131 C uptake and provide an explanation why certain biochemically nonfunctioning adrenocortical adenomas are visualized with I-131 C.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |